Spironolactone for the Treatment of Acne: A 4-Year Retrospective Study

    January 2017 in “ Dermatology ”
    Radhika Grandhi, Ali Alikhan
    Studysummary In this retrospective study, spironolactone improved acne in 86% of patients while showing minimal side effects, suggesting it as a safe treatment option for postadolescent acne with a low risk of short-term adverse effects like hyperkalemia.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on karger.com →
    Discuss this study in the Community →

    Research cited in this study 1

    1. Hormonal Therapy for Acne: Why Not as First Line Therapy? Facts and Controversies Clinics in Dermatology · 2009